The Angus Reid Canadian Pain Management study
, found that a third of those surveyed say they missed work in the past year because of pain. Three out of four respondents say they avoid taking pain pills because of concerns about side-effects, which means tens-of-thousands of Canadians are suffering without relief.
In 2010, Statistics Canada
estimated that more than 1-in-10 or 1.5 million Canadians aged 12 to 44 live with chronic pain, everything from migraines to back pain, that affects their daily activities including employment.
But now Canadian bio-research company Delivra, that commissioned the study, claims
it has developed a new transdermal way to transfer pain relief medication through the skin to joints, muscles and other tissues. The company says Dr. Joseph Gabriel developed the system through 6-years of research and officials believe it will change treatment options for patients looking for alternative pain relief remedies.
In a news release
, Delivera claims the new topical pain creams are six times stronger than anything currently on the market and are safe for use on children.
The federal government is backing the breakthrough, by investing in further research at a new lab that opened
this week in Charlottetown, PEI.
Pain relief isn't the only application for the product. The company says, among other uses, it hopes to be able to provide the same anti-aging benefits
from a topical cream that are now only available through cosmetic injectables. While no specifics were given, currently products like Botox and Restylane are only available through injection.